LABORATORIO FARMAC.ERFO (RK7) — Capital Reinvestment Ratio
LABORATORIO FARMAC.ERFO (RK7) has a Capital Reinvestment Ratio of 1.11x as of December 2023, meaning it reinvests 1% of its operating cash flow (€1.30 Million) in capital expenditures (€1.45 Million). Check RK7 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LABORATORIO FARMAC.ERFO Capital Reinvestment Ratio (2021–2023)
This chart tracks LABORATORIO FARMAC.ERFO's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of LABORATORIO FARMAC.ERFO.
Annual Capital Reinvestment Ratio for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year Capital Reinvestment Ratio for LABORATORIO FARMAC.ERFO from 2021 to 2023. See LABORATORIO FARMAC.ERFO (RK7) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.11x | €1.30 Million | €1.45 Million | ▼ -27.9% |
| 2022 | 1.55x | €761.80K | €1.18 Million | ▲ +1347.6% |
| 2021 | 0.11x | €2.27 Million | €242.84K | — |